Skip to content

Immunai

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Immunai raises $215 million in Series B funding

    Immunai raised $215 million in a Series B funding round led by Koch Disruptive Technologies. The article says the company planned to use the funds to expand its drug actuary platform.